-
1
-
-
84868560972
-
Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer
-
Terashima M, Kitada K, Ochiai A, Ichikawa W, Kurahashi I, Sakuramoto S, Katai H, Sano T, Imamura H and Sasako M: Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res 18: 5992-6000, 2012.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 5992-6000
-
-
Terashima, M.1
Kitada, K.2
Ochiai, A.3
Ichikawa, W.4
Kurahashi, I.5
Sakuramoto, S.6
Katai, H.7
Sano, T.8
Imamura, H.9
Sasako, M.10
-
2
-
-
0017594340
-
Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer
-
Fujimoto S, Akao T, Itoh B, Koshizuka I, Koyano K, Kitsukawa Y, Takahashi M, Minami T, Ishigami H, Miyazaki M, Amamiya K, Ohyama Y, Ono K, Kure M, Itoh Kenjiro and Hikosaka Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer. Ann Surg 185: 462-466, 1977.
-
(1977)
Ann Surg
, vol.185
, pp. 462-466
-
-
Fujimoto, S.1
Akao, T.2
Itoh, B.3
Koshizuka, I.4
Koyano, K.5
Kitsukawa, Y.6
Takahashi, M.7
Minami, T.8
Ishigami, H.9
Miyazaki, M.10
Amamiya, K.11
Ohyama, Y.12
Ono, K.13
Kure, M.14
Kenjiro, I.15
Hikosaka16
-
3
-
-
0033166516
-
Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting meta-analysis of randomized trials
-
Earle CC and Maroun JA: Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting meta-analysis of randomized trials. Eur J Cancer 35: 1059-1064, 1999.
-
(1999)
Eur J Cancer
, vol.35
, pp. 1059-1064
-
-
Earle, C.C.1
Maroun, J.A.2
-
4
-
-
0033816806
-
Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomized trials
-
Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, Cascinu S, Barni S, Labianca R and Torri V: Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomized trials. Ann Oncol 11: 837-843, 2000.
-
(2000)
Ann Oncol
, vol.11
, pp. 837-843
-
-
Mari, E.1
Floriani, I.2
Tinazzi, A.3
Buda, A.4
Belfiglio, M.5
Valentini, M.6
Cascinu, S.7
Barni, S.8
Labianca, R.9
Torri, V.10
-
5
-
-
35748946650
-
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
-
Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A and Arai K: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357: 1810-1820, 2007.
-
(2007)
N Engl J Med
, vol.357
, pp. 1810-1820
-
-
Sakuramoto, S.1
Sasako, M.2
Yamaguchi, T.3
Kinoshita, T.4
Fujii, M.5
Nashimoto, A.6
Furukawa, H.7
Nakajima, T.8
Ohashi, Y.9
Imamura, H.10
Higashino, M.11
Yamamura, Y.12
Kurita, A.13
Arai, K.14
-
6
-
-
79959373978
-
Japanese gastric cancer treatment guidelines 2010
-
Japanese Gastric Cancer Association: ver. 3
-
Japanese Gastric Cancer Association: Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 14: 113-123, 2011.
-
(2011)
Gastric Cancer
, vol.14
, pp. 113-123
-
-
-
7
-
-
81755171104
-
Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage or III gastric cancer
-
Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T, Nashimoto A, Fujii M, Nakajima T and Ohashi Y: Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage or III gastric cancer. J Clin Oncol 29: 4387-4393, 2011.
-
(2011)
J Clin Oncol
, vol.29
, pp. 4387-4393
-
-
Sasako, M.1
Sakuramoto, S.2
Katai, H.3
Kinoshita, T.4
Furukawa, H.5
Yamaguchi, T.6
Nashimoto, A.7
Fujii, M.8
Nakajima, T.9
Ohashi, Y.10
-
8
-
-
33750370444
-
MicroRNA signatures in human cancers
-
Calin G and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 857-866
-
-
Calin, G.1
Croce, C.M.2
-
9
-
-
20444460289
-
MicroRNA expression profiles classify human cancers
-
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR and Golub TR: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
-
(2005)
Nature
, vol.435
, pp. 834-838
-
-
Lu, J.1
Getz, G.2
Miska, E.A.3
Alvarez-Saavedra, E.4
Lamb, J.5
Peck, D.6
Sweet-Cordero, A.7
Ebert, B.L.8
Mak, R.H.9
Ferrando, A.A.10
Downing, J.R.11
Jacks, T.12
Horvitz, H.R.13
Golub, T.R.14
-
10
-
-
72449142765
-
MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
-
Hummel R, Hussey DJ and Haier J: MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 46: 298-311, 2010.
-
(2010)
Eur J Cancer
, vol.46
, pp. 298-311
-
-
Hummel, R.1
Hussey, D.J.2
Haier, J.3
-
11
-
-
40749153540
-
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial
-
Koizumi W, Narahara H, Hara T, Takagane A, Akiya Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H and Takeuchi M: S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9: 215-221, 2008.
-
(2008)
Lancet Oncol
, vol.9
, pp. 215-221
-
-
Koizumi, W.1
Narahara, H.2
Hara, T.3
Takagane, A.4
Akiya Takagi, M.5
Miyashita, K.6
Nishizaki, T.7
Kobayashi, O.8
Takiyama, W.9
Toh, Y.10
Nagaie, T.11
Takagi, S.12
Yamamura, Y.13
Yanaoka, K.14
Orita, H.15
Takeuchi, M.16
-
12
-
-
79958060654
-
MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples
-
Osawa S, Shimada Y, Sekine S, Okumura T, Nagata T, Fukuoka J and Tsukada K: MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples. Oncol Lett 613-619, 2011.
-
(2011)
Oncol Lett
, pp. 613-619
-
-
Osawa, S.1
Shimada, Y.2
Sekine, S.3
Okumura, T.4
Nagata, T.5
Fukuoka, J.6
Tsukada, K.7
-
13
-
-
79251482754
-
Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: A meta-analysis
-
Xing Y, Bronstein Y, Ross MI, Askew RL, Lee JE, Gershenwald JE, Royal R and Cormier JN: Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst 103: 129-142, 2011.
-
(2011)
J Natl Cancer Inst
, vol.103
, pp. 129-142
-
-
Xing, Y.1
Bronstein, Y.2
Ross, M.I.3
Askew, R.L.4
Lee, J.E.5
Gershenwald, J.E.6
Royal, R.7
Cormier, J.N.8
-
14
-
-
33750726715
-
Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer
-
Nakajima G, Hayashi K, Xi Y, Kudo K, Uchida K, Takasaki K, Yamamoto M and Ju J: Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics 3: 317-324, 2006.
-
(2006)
Cancer Genomics Proteomics
, vol.3
, pp. 317-324
-
-
Nakajima, G.1
Hayashi, K.2
Xi, Y.3
Kudo, K.4
Uchida, K.5
Takasaki, K.6
Yamamoto, M.7
Ju, J.8
-
15
-
-
79960077485
-
MYCN-regulated miRNA-92 inhibits secretion the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma
-
Haug BH, Henriksen JR, Buechner J, Geerts D, Tømte E, Kogner P, Martinsson T, Flægstad T, Sveinbjørnsson B and Einvik C: MYCN-regulated miRNA-92 inhibits secretion the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma. Carcinogenesis 32: 1005-1012, 2011.
-
(2011)
Carcinogenesis
, vol.32
, pp. 1005-1012
-
-
Haug, B.H.1
Henriksen, J.R.2
Buechner, J.3
Geerts, D.4
Tømte, E.5
Kogner, P.6
Martinsson, T.7
Flægstad, T.8
Sveinbjørnsson, B.9
Einvik, C.10
-
16
-
-
84877155862
-
miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase
-
Wang K, Wang X, Zou J, Zhang A, Wan Y, Pu P, Song Z, Qian C, Chen Y, Yang S and Wang Y: miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase. Neuro Oncol 15: 578-588, 2013.
-
(2013)
Neuro Oncol
, vol.15
, pp. 578-588
-
-
Wang, K.1
Wang, X.2
Zou, J.3
Zhang, A.4
Wan, Y.5
Pu, P.6
Song, Z.7
Qian, C.8
Chen, Y.9
Yang, S.10
Wang, Y.11
-
17
-
-
33748499794
-
Simple combinations of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1
-
Ichikawa W, Takahashi T, Suto K, Shirota Y, Nihei Z, Shimizu M, Sasaki Y and Hirayama R: Simple combinations of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1. Int J Cancer 119: 1927-1933, 2006.
-
(2006)
Int J Cancer
, vol.119
, pp. 1927-1933
-
-
Ichikawa, W.1
Takahashi, T.2
Suto, K.3
Shirota, Y.4
Nihei, Z.5
Shimizu, M.6
Sasaki, Y.7
Hirayama, R.8
-
18
-
-
80051546264
-
Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer
-
Jeung HC, Rha SY, Shin SJ, Lim SJ, Roh JK, Noh SH and Chung HC: Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer. Anticancer Drugs 22: 801-810, 2011.
-
(2011)
Anticancer Drugs
, vol.22
, pp. 801-810
-
-
Jeung, H.C.1
Rha, S.Y.2
Shin, S.J.3
Lim, S.J.4
Roh, J.K.5
Noh, S.H.6
Chung, H.C.7
-
19
-
-
35349027699
-
Quantitative double-fluorescence immunohistochemistry (qDFIHC), a novel technology to assess protein expression: A pilot study analyzing 5-FU sensitive markers thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferases in gastric cancer tissue specimens
-
Kai K, Kitajima Y, Hiraki M, Satoh S, Tanaka M, Nakafusa Y, Tokunaga O and Miyazaki K: Quantitative double-fluorescence immunohistochemistry (qDFIHC), a novel technology to assess protein expression: a pilot study analyzing 5-FU sensitive markers thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferases in gastric cancer tissue specimens. Cancer Lett 258: 45-54, 2007.
-
(2007)
Cancer Lett
, vol.258
, pp. 45-54
-
-
Kai, K.1
Kitajima, Y.2
Hiraki, M.3
Satoh, S.4
Tanaka, M.5
Nakafusa, Y.6
Tokunaga, O.7
Miyazaki, K.8
-
20
-
-
79958048319
-
Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response
-
Gougelet A, Pissaloux D, Besse A, Perez J, Duc A, Dutour A, Blay JY and Alberti L: Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response. Int J Cancer 129: 680-690, 2011.
-
(2011)
Int J Cancer
, vol.129
, pp. 680-690
-
-
Gougelet, A.1
Pissaloux, D.2
Besse, A.3
Perez, J.4
Duc, A.5
Dutour, A.6
Blay, J.Y.7
Alberti, L.8
-
21
-
-
84868144684
-
Identification and functional screening of microRNAs highly deregulated in colorectal cancer
-
Faltejskova P, Svoboda M, Srutova K, Mlcochova J, Besse A, Nekvindova J, Radova L, Fabian P, Slaba K, Kiss I, Vyzula R and Slaby O: Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J Cell Mol Med 16: 2655-2666, 2012.
-
(2012)
J Cell Mol Med
, vol.16
, pp. 2655-2666
-
-
Faltejskova, P.1
Svoboda, M.2
Srutova, K.3
Mlcochova, J.4
Besse, A.5
Nekvindova, J.6
Radova, L.7
Fabian, P.8
Slaba, K.9
Kiss, I.10
Vyzula, R.11
Slaby, O.12
-
22
-
-
63249099917
-
Functional links between clustered microRNAs: Suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer
-
Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, Hur K, Yoo MW, Lee HJ, Yang HK and Kim VN: Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 37: 1672-1681, 2009.
-
(2009)
Nucleic Acids Res
, vol.37
, pp. 1672-1681
-
-
Kim, Y.K.1
Yu, J.2
Han, T.S.3
Park, S.Y.4
Namkoong, B.5
Kim, D.H.6
Hur, K.7
Yoo, M.W.8
Lee, H.J.9
Yang, H.K.10
Kim, V.N.11
-
23
-
-
77955429106
-
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
-
Zhang CZ, Han L, Zhang AL, Fu YC, Yue X, Wang GX, Jia ZF, Pu PY, Zhang QY and Kang CS: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 10: 367-376, 2010.
-
(2010)
BMC Cancer
, vol.10
, pp. 367-376
-
-
Zhang, C.Z.1
Han, L.2
Zhang, A.L.3
Fu, Y.C.4
Yue, X.5
Wang, G.X.6
Jia, Z.F.7
Pu, P.Y.8
Zhang, Q.Y.9
Kang, C.S.10
-
24
-
-
79959251756
-
Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection
-
Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui J and Liu Y: Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann Oncol 22: 2257-2266, 2011.
-
(2011)
Ann Oncol
, vol.22
, pp. 2257-2266
-
-
Zhang, X.1
Yan, Z.2
Zhang, J.3
Gong, L.4
Li, W.5
Cui, J.6
Liu, Y.7
|